StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.37−0.37 (-2.09%)

Close on Nov 18, 2026Market cap $474.25MP/E –Yield –

Earnings

Carlsmed's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$21.60M
+64.9% on a year earlier
Adjusted Net Loss Per Share, Q3 FY2026
-$0.34
-$0.40 a year earlier
Latest guidance
Raised
Nov 10, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Carlsmed's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026after the close$21.60M+64.9%-$0.45-$0.34Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$18.90M+56.2%-$0.39–Release
Q1 FY2026ended Mar 31, 2026May 5, 2026after the close$16.10M–-$0.32–Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$15.20M–-$0.32–Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$13.10M–-$0.40–Release
Q2 FY2025ended Jun 30, 2025Aug 28, 2025after the close$12.10M–-$1.47–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Carlsmed's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueFY2026$78.00M – $80.00M$70.00M – $75.00MRaisedNov 10, 2026
RevenueFY2026$74.00M – $78.00M$72.00M – $77.00MRaisedAug 5, 2026

Guidance history

Every forecast Carlsmed put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 10, 2026RevenueFY2026$78.00M – $80.00MRaised
Aug 5, 2026RevenueFY2026$74.00M – $78.00MRaised
May 5, 2026RevenueFY2026$72.00M – $77.00MNew
Feb 25, 2026RevenueFY2026$70.00M – $75.00MNew
Nov 6, 2025RevenueFY2025$49.00M – $50.00MNew
Aug 28, 2025RevenueFY2025$45.50M – $47.50MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Carlsmed filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?